Literature DB >> 19234128

Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance.

Ian A Parish1, Jason Waithman, Gayle M Davey, Gabrielle T Belz, Justine D Mintern, Christian Kurts, Robyn M Sutherland, Francis R Carbone, William R Heath.   

Abstract

Autoimmune diseases tend to be chronic and progressive, but how these responses are sustained is not clear. One cell type that might contribute to autoimmunity is the cytotoxic T lymphocyte (CTL), which, as a consequence of causing tissue destruction and production of cytokines, could provide a sustained supply of antigen and inflammatory signals for dendritic cells to maintain immune stimulation. Here we examined whether such CTL-mediated tissue damage alone could provide antigen in the right context to recruit immune effectors and sustain autoimmunity. We show that while CTL-mediated tissue damage caused the release of self-antigens that stimulated the proliferation of naive autoreactive CD8(+) T cells, such responses failed to precipitate disease and, instead, led to deletional tolerance. These findings indicate that despite the capacity of CTLs to produce inflammatory cytokines and to cause tissue damage, their responses are not sustaining, but instead favor induction of self-tolerance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234128      PMCID: PMC2656177          DOI: 10.1073/pnas.0810427106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Epitope spreading in immune-mediated diseases: implications for immunotherapy.

Authors:  Carol L Vanderlugt; Stephen D Miller
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells.

Authors:  M L Albert; M Jegathesan; R B Darnell
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

4.  Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

Authors:  Geoffrey B Johnson; Gregory J Brunn; Yuzo Kodaira; Jeffrey L Platt
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

5.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

Authors:  Steffen Jung; Derya Unutmaz; Phillip Wong; Gen-Ichiro Sano; Kenia De los Santos; Tim Sparwasser; Shengji Wu; Sri Vuthoori; Kyung Ko; Fidel Zavala; Eric G Pamer; Dan R Littman; Richard A Lang
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

6.  Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells.

Authors:  Stéphanie Hugues; Evelyne Mougneau; Walter Ferlin; Dirk Jeske; Paul Hofman; Dirk Homann; Lucie Beaudoin; Corinne Schrike; Matthias Von Herrath; Agnès Lehuen; Nicolas Glaichenhaus
Journal:  Immunity       Date:  2002-02       Impact factor: 31.745

7.  Characterization of two TCR transgenic mouse lines specific for herpes simplex virus.

Authors:  Scott N Mueller; WilliamR Heath; Julie D McLain; Francis R Carbone; Claerwen M Jones
Journal:  Immunol Cell Biol       Date:  2002-04       Impact factor: 5.126

8.  Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

Authors:  Christian Termeer; Frauke Benedix; Jonathon Sleeman; Christina Fieber; Ursula Voith; Thomas Ahrens; Kensuke Miyake; Marina Freudenberg; Christopher Galanos; Jan Christoph Simon
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

9.  The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens.

Authors:  Gabrielle T Belz; Georg M N Behrens; Chris M Smith; Jacques F A P Miller; Claerwen Jones; Kristina Lejon; C Garrison Fathman; Scott N Mueller; Ken Shortman; Francis R Carbone; William R Heath
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

10.  Immune tolerance after delivery of dying cells to dendritic cells in situ.

Authors:  Kang Liu; Tomonori Iyoda; Marzena Saternus; Yukino Kimura; Kayo Inaba; Ralph M Steinman
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more
  8 in total

1.  Autoimmune vitiligo does not require the ongoing priming of naive CD8 T cells for disease progression or associated protection against melanoma.

Authors:  Katelyn T Byrne; Peisheng Zhang; Shannon M Steinberg; Mary Jo Turk
Journal:  J Immunol       Date:  2014-01-08       Impact factor: 5.422

Review 2.  In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.

Authors:  Valentina Di Caro; Nick Giannoukakis; Massimo Trucco
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 3.  Diversity in CD8(+) T cell differentiation.

Authors:  Ian A Parish; Susan M Kaech
Journal:  Curr Opin Immunol       Date:  2009-06-06       Impact factor: 7.486

Review 4.  Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  J Immunol       Date:  2022-02-01       Impact factor: 5.426

5.  Forced expression of IL-7R promotes CD8 T cell cytotoxicity to self antigen.

Authors:  YuFeng Peng
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

6.  Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.

Authors:  Kunal H Bhatt; Rajeev Rudraraju; Jeremy F Brooks; Ji-Won Jung; Ryan Galea; James W Wells; Raymond J Steptoe
Journal:  Stem Cell Res Ther       Date:  2017-03-09       Impact factor: 6.832

Review 7.  Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy.

Authors:  Simone Nüssing; Joseph A Trapani; Ian A Parish
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

8.  GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions.

Authors:  Judith Agudo; Albert Ruzo; Eun Sook Park; Robert Sweeney; Veronika Kana; Meng Wu; Yong Zhao; Dieter Egli; Miriam Merad; Brian D Brown
Journal:  Nat Biotechnol       Date:  2015-11-02       Impact factor: 54.908

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.